How to Get HIPAA for a Healthtech Company

The Direct Answer: How a Healthtech Company Becomes HIPAA Compliant

If your healthtech company just got asked for a HIPAA attestation, a security addendum, or a Business Associate Agreement (BAA) from a US health system, hospital network, or payer, you are not alone, and you are not behind schedule if you start now. HIPAA compliance for a digital health company selling into the US market means: (1) confirming your Covered Entity/Business Associate status, (2) completing a formal Security Risk Assessment (SRA) under the HIPAA Security Rule, (3) closing technical, administrative, and physical safeguard gaps around Protected Health Information (PHI), (4) documenting policies and Business Associate Agreements with every subprocessor that touches PHI, and (5) getting an independent third party to validate the program before you sign a BAA with an enterprise buyer. For most venture-backed healthtech companies, this is a readiness engagement, not a certification body audit. HIPAA has no official "certification," so the deliverable your buyers actually want is a credible attestation of a functioning compliance program, often paired with a SOC 2 Type II report that covers the same technical controls.

Why Healthtech Companies Get This Question Now

The trigger is almost always the same: a hospital system, digital health platform, or payer partner has sent a vendor security questionnaire, and buried in it is a line item asking for your HIPAA compliance status and a signed BAA before contracts move forward. Sometimes it comes from the investor side instead, a Series A or B diligence team wants to see that PHI handling is not a liability sitting on the cap table. Either way, the deal or the round is paused on a document you probably do not have yet, and the sales or product team suddenly needs an answer with a timeline attached, not a promise.

Canadian healthtech founders face a specific wrinkle here. You may already be handling PIPEDA obligations, or Quebec Law 25 if you have Quebec-based staff or users, and now a US healthtech buyer is layering HIPAA on top. The good news is that the underlying security engineering work overlaps heavily: encryption at rest and in transit, access controls, audit logging, incident response, and vendor risk management satisfy both frameworks in large part. The compliance work is additive, not duplicative, if you scope it correctly from the start.

Step 1: Determine Whether You Are a Covered Entity or a Business Associate

Most healthtech SaaS companies are Business Associates: you create, receive, maintain, or transmit PHI on behalf of a Covered Entity (a hospital, clinic, health plan, or provider). This classification determines your obligations under the HIPAA Security Rule and Privacy Rule, and it determines who needs a signed BAA with whom. Map your data flows first: where does PHI enter your system, where is it stored, who touches it internally, and which vendors (cloud hosting, analytics, support tooling, email) also touch it. Every one of those vendors needs its own BAA in place before you can honestly tell a buyer your program is complete.

Step 2: Run a Formal Security Risk Assessment

The Security Risk Assessment (SRA) is the foundation the entire program is built on, and it is also the first artifact enterprise buyers ask to see evidence of. It requires a systematic review of where electronic PHI (ePHI) lives, what threats and vulnerabilities exist against it, and what safeguards are already in place versus what is missing. This is where most healthtech companies discover their real gap list: unencrypted backups, shared admin credentials, no formal access review cadence, or a logging setup that cannot answer "who accessed this patient record and when." The SRA is not a one-time checkbox either; HHS expects it to be revisited as your architecture changes.

Step 3: Close the Administrative, Physical, and Technical Safeguard Gaps

HIPAA's Security Rule organizes requirements into three safeguard categories, and a readiness engagement works through each one methodically.

• Administrative safeguards: designate a security officer, formalize workforce training, build an incident response plan, and document a sanctions policy for violations.
• Physical safeguards: control facility access where servers or workstations touch PHI, and this is largely inherited from your cloud provider if you are running on AWS, GCP, or Azure with a signed BAA in place.
• Technical safeguards: encryption of ePHI at rest and in transit, unique user IDs, automatic session logoff, audit controls that log access to patient data, and integrity controls that detect unauthorized alteration.

Most engineering-led healthtech teams already have a chunk of the technical safeguards built by default because good security practice and HIPAA overlap. The gaps almost always surface in the administrative layer, the policies, the training records, the documented risk decisions, because that is the paperwork engineers do not naturally produce while shipping product.

Step 4: Put Business Associate Agreements in Place Everywhere PHI Travels

Every subprocessor that can access ePHI, cloud infrastructure, error monitoring, customer support platforms, email providers, needs a BAA on file, and you need an internal inventory proving it. Enterprise health buyers will ask for this vendor list directly. If a tool in your stack cannot or will not sign a BAA, that is a build-versus-buy decision that needs to happen before your gap assessment closes, not after a buyer discovers it during their own vendor risk review.

Step 5: Bring in an Independent Party to Validate the Program

Because HIPAA has no formal certifying body, the credibility of your compliance posture rests on independent validation. This is where traztech's model matters: we run the fixed-scope gap analysis and remediation roadmap as the readiness partner, and an independent CPA firm performs the actual attestation work, because the party that finds and fixes gaps should not be the same party that signs off on them. Many US healthtech buyers are satisfied by a SOC 2 Type II report scoped to include HIPAA-mapped controls rather than a full HITRUST CSF certification, which is a heavier, more expensive undertaking usually reserved for larger, later-stage vendors. Running HIPAA readiness alongside a SOC 2 engagement means you are not duplicating evidence collection twice, since the two frameworks share most of the same technical control evidence. For a deeper breakdown of what US healthtech buyers specifically expect to see, see our guide on HIPAA compliance for digital health companies.

What a Realistic Timeline Looks Like

For a healthtech company with a reasonably modern cloud stack and no prior compliance work, a HIPAA readiness engagement paired with SOC 2 typically runs on this shape:

• Weeks 1 to 2: gap assessment and PHI data flow mapping
• Weeks 3 to 6: remediation of technical and administrative safeguard gaps, policy drafting, BAA collection
• Weeks 6 to 12: evidence collection running in parallel with a SOC 2 Type I or the observation window for Type II
• Ongoing: annual SRA refresh and continuous monitoring as your enterprise deal pipeline grows

Founders who start this the week a deal stalls, rather than the week the contract is due to sign, generally close the enterprise deal on time instead of losing a quarter to it.

What US Healthtech Buyers Actually Ask For

In practice, the vendor security questionnaires and BAA negotiations from US health systems and digital health platforms converge on a short list: a completed and dated Security Risk Assessment, evidence of encryption for ePHI at rest and in transit, a named security officer and incident response plan, a signed BAA with a defined breach notification clause, and increasingly, a SOC 2 report as third-party corroboration that the controls are real and operating, not just documented on paper. Buyers rarely require full HITRUST certification from an early or mid-stage vendor; they want proof the program exists and is independently reviewed.

Get a Clear Picture of Your Gaps Before the Deal Deadline Arrives

If a US healthtech buyer, hospital system, or investor has already put HIPAA on the table, the fastest way to protect that revenue is a fixed-scope look at exactly where your program stands today. Book a free readiness call with traztech and get a clear, prioritized gap list mapped against the HIPAA Security Rule, with an estimated timeline for closing it before your deal or renewal deadline hits. If you would rather talk through your specific situation first, including how to run HIPAA and SOC 2 together without duplicating work, contact our team and we will help you scope the right path forward.

Required Versus Addressable, and Why That Trips People Up

The Security Rule splits implementation specifications into required and addressable, and the word addressable causes more trouble than any other term in HIPAA. It does not mean optional. It means you must assess whether the specification is reasonable and appropriate for your environment, implement it if it is, and if it is not, document why and implement an equivalent alternative measure that achieves the same purpose.

Encryption of ePHI at rest is the classic example. It is addressable, which some teams read as permission to skip it. In a cloud-native healthtech company running on managed databases where encryption is a checkbox, there is no defensible argument that it is unreasonable, so skipping it is a finding waiting to happen. The written decision is the artifact that matters. An enterprise buyer's security team, and an OCR investigator if it ever comes to that, will ask to see the analysis behind an addressable specification you did not implement. "We discussed it" is not the answer. A dated memo naming the specification, the assessment, the alternative measure, and the person who approved it is.

Build a register of every addressable specification with your position on each. Automatic logoff, encryption at rest, encryption in transit, emergency access procedure, integrity controls for transmitted ePHI. It takes an afternoon once your risk assessment is done and it closes off the single most common gap in a healthtech program that otherwise looks solid.

Your Breach Clock Is Shorter Than HIPAA's

Founders read the sixty-day breach notification requirement and plan accordingly. That number is the Covered Entity's obligation to notify affected individuals. Your obligation as a Business Associate is to notify the Covered Entity, and the window for that is whatever your BAA says. Enterprise health systems routinely write in five business days, sometimes seventy-two hours, occasionally twenty-four for a suspected incident rather than a confirmed one. If you sign twelve BAAs with twelve different clocks, your incident response plan has to run to the shortest one because you will not have time to look them up while the incident is live.

The other mechanic worth knowing is the presumption. Under the Breach Notification Rule an impermissible use or disclosure of unsecured PHI is presumed to be a breach unless you can demonstrate low probability of compromise through a documented risk assessment covering the nature and extent of the PHI, who received or accessed it, whether it was actually acquired or viewed, and the extent to which the risk has been mitigated. That assessment is not optional paperwork. It is the mechanism by which a misdirected email to the wrong clinic becomes a documented non-breach rather than a notification event.

The safe harbor is encryption. PHI encrypted to the standard referenced by HHS guidance is not unsecured PHI, and its loss is not a reportable breach. That single fact is why encryption decisions deserve more attention than most of the policy work around them.

The BAA Clauses That Actually Cost You Money

Most founders sign the health system's BAA template unread because the deal is waiting. Four clauses are worth an hour of legal time.

Notification window. Negotiate to a workable number and define the trigger as confirmed incident rather than suspicion of one, or you will be sending notifications every time an alert fires.

Subcontractor flow-down. You are required to obtain satisfactory assurances from subcontractors that create, receive, maintain, or transmit PHI on your behalf. Some templates go further and require prior written approval for each subcontractor, which sounds harmless until you want to change error monitoring vendors and need sign-off from eleven customers.

Return or destruction on termination. The obligation is to return or destroy all PHI at the end of the agreement where feasible. If your architecture cannot delete a single customer's data from backups, say so and extend the protections instead of promising something your system cannot do. Auditors and buyers test this claim.

Audit and indemnity. On-site audit rights from a large health system are usually acceptable in practice because they are rarely exercised. Uncapped indemnity for breach costs is a different matter and belongs in front of counsel before signature, particularly if the same clause appears across a dozen agreements.

De-identification Is Not a Shortcut You Probably Qualify For

Teams frequently tell us their analytics pipeline is out of scope because the data is de-identified. Under HIPAA that word has two specific meanings. Safe Harbor requires the removal of eighteen categories of identifier, including all elements of dates other than year, all geographic subdivisions smaller than a state with a population rule attached to the first three ZIP digits, device identifiers, and any other unique identifying number or code. Expert determination requires a qualified statistician to document that the risk of re-identification is very small.

Stripping names and replacing the medical record number with a UUID satisfies neither. Full dates of service alone break Safe Harbor, and most product analytics depend on exactly those dates. If de-identification is load-bearing in your architecture, either meet one of the two methods properly and document it, or accept that the pipeline is in scope and control it accordingly. Discovering this during a buyer's review is worse than discovering it now.

The Tooling That Quietly Holds PHI

PHI leaks sideways into systems nobody mapped. The recurring offenders in healthtech are the support desk, where a patient pastes their symptoms and record number into a ticket; error monitoring, where a stack trace captures a request body containing patient data; session replay tools that record the clinician's screen; analytics events with identifiers in the properties; and Slack, where an engineer shares a screenshot to debug something at 11pm.

Each of those either needs a BAA and controls, or needs to stop receiving PHI. The second option is usually cheaper and always more defensible. Scrub request bodies before they reach your error tracker, mask fields in session replay, and put a hard rule around debugging with production data. The related habit worth building is access logging that can answer a specific question: which internal user viewed which patient record, when, and from where. Your database may log queries, but a query log is not an answer to that question, and every enterprise health buyer asks it.

Canadian Healthtech: PHIPA Runs Alongside, Not Instead

An Ontario healthtech company serving both Canadian clinics and US health systems carries two regimes at once. If you provide services to a health information custodian in Ontario, you are likely an agent or an electronic service provider under PHIPA, which brings its own obligations including notice to the custodian at the first reasonable opportunity, restrictions on using the information for your own purposes, and specific duties for those acting as a health information network provider. Quebec adds Law 25 requirements for personal information, and PIPEDA sits underneath for commercial activity outside a custodian relationship.

The technical controls overlap almost entirely, so the engineering work is done once. What does not overlap is the paperwork: your PHIPA obligations to a Canadian custodian are not discharged by a US-style BAA, and your notification duties differ in trigger and timing. Map them side by side rather than assuming the heavier framework covers the lighter one.

When You Should Not Start a HIPAA Program

Some healthtech companies are told they need HIPAA and do not. If you never touch identifiable health information, because you sell scheduling analytics on aggregate counts or you operate strictly business-to-business with no patient data crossing your boundary, then the honest answer to the questionnaire is that you are not a Business Associate, and a paragraph explaining your data flows will satisfy a competent reviewer faster than a compliance program will.

If you are pre-product and one hospital pilot is in front of you, resist the urge to build the full program. Do the risk assessment, encrypt everything, get the BAAs signed with your cloud and tooling vendors, write the policies you can actually follow, and defer the rest until you have more than one buyer asking. A twenty-page policy set that describes a security function you do not employ generates findings rather than confidence.

And if a buyer has asked for HITRUST specifically, check whether that is a hard requirement or a preference. It is a materially heavier and more expensive path than a SOC 2 report with HIPAA-mapped controls, and it is frequently listed as preferred by procurement teams who will accept the lighter evidence when asked directly. Ask before you budget for it.

When the work is genuinely in front of you, our HIPAA readiness for digital health engagement is scoped to the data you actually touch, and the free traztech Workspace will hold your BAA inventory, risk assessment, and addressable-specification decisions whether or not you ever hire us. If you are unsure which of the situations above you are in, describe your data flows to us and we will tell you plainly.